Impact of Hot Flashes on Sleep and Mood Disturbance

Completed · Phase 4

Conditions studied: Menopause, Depression, Hot Flashes

In brief

We plan to enroll premenopausal women in a trial investigating the impact of hot flashes developed in response to an injection of a gonadotropin-releasing hormone agonist (GnRHa), leuprolide (brand name: Lupron), on sleep disruption and mood. This study is designed to mimic the menopause transition. We will collect data on sleep disruption and mood changes to assess their relationship to the development of hot flashes.

Key facts

Study ID
NCT01116401
Run by
Massachusetts General Hospital
People needed
29
Starts
2009-11-03
Expected to finish
2012-01-04
Last updated by the study team
2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.